The Cigna Group Q3 2025 Earnings: Strong Results & New Rebate-Free Pharmacy Model

Q3 2025 Financial Performance

• 📊 The Cigna Group reported strong third-quarter 2025 results, with revenues of $69.7 billion and adjusted earnings per share of $7.83.
• 📈 The company reaffirmed its full-year 2025 adjusted EPS outlook of at least $29.60, demonstrating confidence in its financial commitments.
• 💰 Operating cash flow for Q3 2025 was $3.4 billion, with strong cash flow expected to continue into the fourth quarter.

Transforming Pharmacy Benefits

• ✨ Cigna is introducing a transformative new rebate-free model for pharmacy benefit services, replacing complex post-purchase rebates with upfront discounts.
• 💡 This model aims to ensure customers and patients automatically pay the lowest price at the counter, potentially reducing brand-name drug costs by 30% for certain plans.
• ✅ The new model will be adopted by Cigna Healthcare for fully insured lives by 2027 and become the standard offering for the broader Cigna Group by January 2028.
• 🤝 Cigna is committed to creating a sustainable economic model for independent pharmacists, offering fair competitive pricing and dispensing fee reimbursements.

Strategic Growth and Innovation

• 🚀 The company continues to invest strategically, including an investment in Shields Health Solutions to expand specialty capabilities in the over $400 billion specialty market.
• 🌐 Cigna operates across two growth platforms: Cigna Healthcare (40% of enterprise earnings) and Evernorth Health Services (Specialty & Care 30%, Pharmacy Benefit Services 30%).
• 💊 Evernorth's Specialty and Care Services delivered 11% adjusted earnings growth in Q3, driven by strong volume and increased biosimilar adoption, saving patients millions.

2026 Outlook and Investments

• 🎯 Cigna anticipates overall EPS growth in 2026, despite significant investments and transitional costs in its Pharmacy Benefit Services (PBS) segment.
• ⚠️ Evernorth's operating income is expected to be slightly down in 2026, primarily due to margin pressure in PBS from large client renewals and investments in the new rebate-free model.
• 📈 Both Specialty and Care Services and Cigna Healthcare are projected to achieve operating income growth towards the higher end of their long-term targets in 2026.
• ⏳ The investment and transitional costs for the new model are expected to continue into 2027, with the business anticipating a return to its long-term growth algorithm at the enterprise level in 2027.